Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: A meta-Analysis

Critical Care Medicine

Volumn 42, Issue 7, 2014, Pages 1703-1713

  Safdar, Nasia ^a,b   O'Horo, John C ^c   Ghufran, Aiman ^b   Bearden, Allison ^b   Didier, Maria Eugenia ^b   Chateau, Dan ^d   Maki, Dennis G ^b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

catheter related infection; chlorhexidine; nosocomial infection

Indexed keywords

CHLORHEXIDINE;

ARTERY CATHETER; BACTERIAL COLONIZATION; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER RELATED COLONIZATION; CHLORHEXIDINE IMPREGNATED DRESSING; CONTACT DERMATITIS; ESCHERICHIA COLI; GAUZE DRESSING; HEMATOLOGIC MALIGNANCY; HEMODYNAMIC MONITORING; HUMAN; LOW BIRTH WEIGHT; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SYSTEMATIC REVIEW;

ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; CATHETER-RELATED INFECTIONS; CHLORHEXIDINE; EQUIPMENT CONTAMINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84902545830     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000319     Document Type: Review

References (61)

1. Climo M, Diekema D, Warren DK, et al: Prevalence of the use of central venous access devices within and outside of the intensive care unit: Results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 2003; 24:942-945
2. Shlaes DM, Gerding DN, John JF Jr, et al: Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25:584-599
3. Mermel LA, Allon M, Bouza E, et al: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45
4. O'grady NP, Alexander M, Dellinger EP, et al; Healthcare Infection Control Practices Advisory Committee: Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002; 30:476-489
5. Mermel LA, Farr BM, Sherertz RJ, et al; Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America: Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-1272
6. Safdar N, Crnich CJ, Maki DG: The pathogenesis of ventilator-Associated pneumonia: Its relevance to developing effective strategies for prevention. Respir Care 2005; 50:725-739; discussion 739-741
7. Safdar N, Crnich CJ, Maki DG: Nosocomial infections in the intensive care unit associated with invasive medical devices. Curr Infect Dis Rep 2001; 3:487-495
8. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-1601
9. Arnow PM, Quimosing EM, Beach M: Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16:778-784
10. Collignon PJ: Intravascular catheter associated sepsis: A common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994; 161:374-378
11. Rello J, Ochagavia A, Sabanes E, et al: Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162:1027-1030
12. Pronovost P, Needham D, Berenholtz S, et al: An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732
13. Mattie AS, Webster BL: Centers for Medicare and Medicaid Services' "never events": An analysis and recommendations to hospitals. Health Care Manag (Frederick) 2008; 27:338-349
14. Clancy CM: CMS's hospital-Acquired condition lists link hospital payment, patient safety. Am J Med Qual 2009; 24:166-168
15. Marrie TJ, Costerton JW: Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol 1984; 19:687-693
16. Cooper GL, Schiller AL, Hopkins CC: Possible role of capillary action in pathogenesis of experimental catheter-Associated dermal tunnel infections. J Clin Microbiol 1988; 26:8-12
17. Sitges-Serra A, Linares J, Garau J: Catheter sepsis: The clue is the hub. Surgery 1985; 97:355-357
18. Maki DG, Jarrett F, Sarafin HW: A semiquantitative culture method for identification of catheter-related infection in the burn patient. J Surg Res 1977; 22:513-520
19. Crnich CJ, Maki DG: The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis 2002; 34:1362-1368
20. Haraden CP: What is a bundle? 2006. Available at: http://www.ihi. org/IHI/Topics/CriticalCare/IntensiveCare/ImprovementStories/WhatIsaBundle.htm. Accessed August 8, 2008
21. Yokoe DS, Mermel LA, Anderson DJ, et al: A compendium of strategies to prevent healthcare-Associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(Suppl 1):S12-S21
22. Eggimann P, Harbarth S, Constantin MN, et al: Impact of a prevention strategy targeted at vascular-Access care on incidence of infections acquired in intensive care. Lancet 2000; 355:1864-1868
23. Berenholtz SM, Pronovost PJ, Lipsett PA, et al: Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014-2020
24. Zingg W, Imhof A, Maggiorini M, et al: Impact of a prevention strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream infections. Crit Care Med 2009; 37:2167-2173; quiz 2180
25. Warren DK, Zack JE, Mayfield JL, et al: The effect of an education program on the incidence of central venous catheter-Associated bloodstream infection in a medical ICU. Chest 2004; 126:1612-1618
26. Coopersmith CM, Zack JE, Ward MR, et al: The impact of bedside behavior on catheter-related bacteremia in the intensive care unit. Arch Surg 2004; 139:131-136
27. Safdar N, Maki DG: The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004; 30:62-67
28. Mermel LA, McCormick RD, Springman SR, et al: The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping. Am J Med 1991; 91:197S-205S
29. Bjornson HS, Colley R, Bower RH, et al: Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 1982; 92:720-727
30. Banton J: Techniques to prevent central venous catheter infections: Products, research, and recommendations. Nutr Clin Pract 2006; 21:56-61
31. Garland JS, Alex CP, Mueller CD, et al: A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107:1431-1436
32. Maki D, Mermel L, Kluger D, et al: The efficacy of a chlorhexidine impregnated sponge (Biopatch) for the prevention of intravascular catheter-related infection-A prospective randomized controlled multicenter study [abstract 1430]. Programs and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 2000; Washington, DC, American Society for Microbiology, p 422
33. Levy I, Katz J, Solter E, et al: Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children-A randomized controlled study. Pediatr Infect Dis J 2005; 24:676-679
34. Chambers ST, Sanders J, Patton WN, et al: Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: Results from a prospective randomized controlled trial. J Hosp Infect 2005; 61:53-61
35. Timsit JF, Schwebel C, Bouadma L, et al; Dressing Study Group: Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: A randomized controlled trial. JAMA 2009; 301: 1231-1241
36. Arvaniti K, Lathyris D, Clouva-Molyvdas P, et al; Catheter-Related Infections in ICU (CRI-ICU) Group: Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: A multicenter, randomized, controlled study. Crit Care Med 2012; 40:420-429
37. Ruschulte H, Franke M, Gastmeier P, et al: Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: A randomized controlled trial. Ann Hematol 2009; 88:267-272
38. Roberts BL, Cheung D: BIOPATCH-A new concept in antimicrobial dressings for invasive devices. Aust Crit Care 1998; 11:16-19
39. Liberati A, Altman DG, Tetzlaff J, et al: The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med 2009; 151:W65-W94
40. Higgins JPT, Green S, Cochrane Collaboration: Cochrane Handbook for Systematic Reviews of Interventions. Chichester, England; Hoboken, NJ, Wiley-Blackwell, 2008
41. DerSimonian R, Laird N: Meta-Analysis in clinical trials. Control Clin Trials 1986; 7:177-188
42. Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in Health Research. Wiley, London, 2000
43. Chaiyakunapruk N, Veenstra DL, Lipsky BA, et al: Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-Analysis. Ann Intern Med 2002; 136:792-801
44. Egger M, Davey Smith G, Schneider M, et al: Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315:629-634
45. Sterne JA, Egger M: Funnel plots for detecting bias in meta-Analysis: Guidelines on choice of axis. J Clin Epidemiol 2001; 54:1046-1055
46. Schwebel C, Lucet JC, Vesin A, et al: Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med 2012; 40:11-17
47. Timsit JF, Mimoz O, Mourvillier B, et al: Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012; 186:1272-1278
48. Ye X, Rupnow M, Bastide P, et al: Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-Associated infections in the United States. Am J Infect Control 2011; 39:647-654
49. Ho KM: Comment on: Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: A meta-Analysis. J Antimicrob Chemother 2010; 65:811-814
50. Tambe SM, Sampath L, Modak SM: In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001; 47:589-598
51. McDonnell G, Russell AD: Antiseptics and disinfectants: Activity, action, and resistance. Clin Microbiol Rev 1999; 12:147-179
52. Penna TC, Mazzola PG, Silva Martins AM: The efficacy of chemical agents in cleaning and disinfection programs. BMC Infect Dis 2001; 1:16
53. Rupp ME, Lisco SJ, Lipsett PA, et al: Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections-A randomized, controlled trial. Ann Intern Med 2005; 143:570-580
54. Maki DG, Stolz SM, Wheeler S, et al: Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997; 127:257-266
55. Tattawasart U, Maillard JY, Furr JR, et al: Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 1999; 42:219-229
56. Cookson BD, Bolton MC, Platt JH: Chlorhexidine resistance in methicillin-resistant Staphylococcus aureus or just an elevated MIC? An in vitro and in vivo assessment. Antimicrob Agents Chemother 1991; 35:1997-2002
57. Horner C, Mawer D, Wilcox M: Reduced susceptibility to chlorhexidine in staphylococci: Is it increasing and does it matter? J Antimicrob Chemother 2012; 67:2547-2559
58. Johnson MD, Schlett CD, Grandits GA, et al: Chlorhexidine does not select for resistance in Staphylococcus aureus isolates in a community setting. Infect Control Hosp Epidemiol 2012; 33:1061-1063
59. O'Horo JC, Silva GL, Munoz-Price LS, et al: The efficacy of daily bathing with chlorhexidine for reducing healthcare-Associated bloodstream infections: A meta-Analysis. Infect Control Hosp Epidemiol 2012; 33:257-267
60. Derde LP, Dautzenberg MJ, Bonten MJ: Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: A systematic review. Intensive Care Med 2012; 38:931-939
61. Climo MW, Sepkowitz KA, Zuccotti G, et al: The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-Associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med 2009; 37:1858-1865